Koshinski Asset Management Inc. Boosts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Koshinski Asset Management Inc. increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 8,896 shares of the healthcare conglomerate’s stock after acquiring an additional 23 shares during the period. Koshinski Asset Management Inc.’s holdings in UnitedHealth Group were worth $4,500,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of UNH. Leonard Rickey Investment Advisors P.L.L.C. boosted its stake in shares of UnitedHealth Group by 8.1% during the fourth quarter. Leonard Rickey Investment Advisors P.L.L.C. now owns 496 shares of the healthcare conglomerate’s stock valued at $251,000 after purchasing an additional 37 shares during the period. Ulland Investment Advisors LLC boosted its position in UnitedHealth Group by 1.2% in the 4th quarter. Ulland Investment Advisors LLC now owns 12,485 shares of the healthcare conglomerate’s stock valued at $6,316,000 after buying an additional 153 shares during the period. Sky Investment Group LLC increased its position in shares of UnitedHealth Group by 2.7% during the fourth quarter. Sky Investment Group LLC now owns 13,306 shares of the healthcare conglomerate’s stock worth $6,731,000 after acquiring an additional 347 shares during the period. Wealthquest Corp boosted its holdings in shares of UnitedHealth Group by 7.8% in the fourth quarter. Wealthquest Corp now owns 470 shares of the healthcare conglomerate’s stock valued at $238,000 after purchasing an additional 34 shares during the period. Finally, Amplius Wealth Advisors LLC increased its holdings in UnitedHealth Group by 11.8% during the 4th quarter. Amplius Wealth Advisors LLC now owns 1,093 shares of the healthcare conglomerate’s stock worth $553,000 after purchasing an additional 115 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.1 %

UNH stock opened at $510.03 on Tuesday. The firm has a market cap of $469.37 billion, a P/E ratio of 32.91, a PEG ratio of 1.39 and a beta of 0.62. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company’s 50-day simple moving average is $549.37 and its 200-day simple moving average is $563.70.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the firm posted $5.83 EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.77 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.65%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on UNH shares. Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Royal Bank of Canada reduced their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Bank of America cut their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday. Finally, UBS Group cut their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.